News Evolent Health, Inc.

Equities

EVH

US30050B1017

Market Closed - Nyse Other stock markets 04:00:02 2024-04-15 pm EDT			5-day change	1st Jan Change
30.3 ^USD	+0.56%		-0.66%	-8.27%

Mar. 28	Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating	MT
Mar. 15	JPMorgan Trims Price Target on Evolent Health to $52 From $53, Maintains Overweight Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating	Mar. 28	MT
JPMorgan Trims Price Target on Evolent Health to $52 From $53, Maintains Overweight Rating	Mar. 15	MT
Transcript : Evolent Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 02:35 PM	Mar. 12
Canaccord Genuity Cuts Price Target on Evolent Health to $45 From $47, Maintains Buy Rating	Feb. 23	MT
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	Feb. 22	MT
Evolent Health: Q4 Earnings Snapshot	Feb. 22	AQ
Transcript : Evolent Health, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	Feb. 22	MT
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	Feb. 22	MT
Evolent Announces Fourth Quarter and Full Year 2023 Results	Feb. 22	PR
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	Feb. 22	CI
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors	Feb. 14	PR
Evolent Health, Inc. Announces Board Changes	Feb. 14	CI
Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024	Jan. 25	PR
Transcript : Evolent Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03:45 PM	Jan. 09
JMP Securities Initiates Evolent Health With Market Outperform Rating, Price Target is $37	Dec. 06	MT
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan	Dec. 05	PR
Evolent Health Plans $350 Million Convertible Senior Notes Offering; Shares Fall	Dec. 05	MT
Evolent Health Shares Drop on $350 Million Note Offering	Dec. 05	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Evolent Health, Inc.

Equities

EVH

US30050B1017

Summary

Filters